# Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation

Study · id `cardio:ct-nct05903170` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05903170](<https://clinicaltrials.gov/study/NCT05903170>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05903170

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05903170. Randomized; no masking; primary purpose treatment. Start 2025-08 (anticipated); primary completion 2026-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05903170, source copy `cardio:ctgov-nct05903170-2025-04-01`, retrieved 2026-10-26)
- Planned start: 2025-08 (anticipated) (ClinicalTrials.gov record NCT05903170, source copy `cardio:ctgov-nct05903170-2025-04-01`, retrieved 2026-10-26)
- Primary completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT05903170, source copy `cardio:ctgov-nct05903170-2025-04-01`, retrieved 2026-10-26)
- Completion: 2026-08 (anticipated) (ClinicalTrials.gov record NCT05903170, source copy `cardio:ctgov-nct05903170-2025-04-01`, retrieved 2026-10-26)
- Countries: New Zealand (ClinicalTrials.gov record NCT05903170, source copy `cardio:ctgov-nct05903170-2025-04-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05903170-2025-04-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Device): 360J LifePak Monitor/Defibrillator
- Intervention (Device): 200J Philips HeartStart MRx Monitor/Defibrillator
- Lead sponsor: Wellington Hospital
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 3037eb70ca8218e2e57ccde0896275249907788412b405034b161b1e980f76c5
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
